US 12,264,152 B2
Certain chemical compositions and methods of use thereof
Andrei W. Konradi, Burlingame, CA (US); Chun-Hao Huang, San Francisco, CA (US); and Ko-Chuan Lee, San Francisco, CA (US)
Assigned to Algen Biotechnologies, Inc., San Francisco, CA (US)
Filed by Algen Biotechnologies, Inc., San Francisco, CA (US)
Filed on Jan. 17, 2023, as Appl. No. 18/097,782.
Application 18/097,782 is a continuation of application No. 17/731,943, filed on Apr. 28, 2022, granted, now 11,591,322.
Application 17/731,943 is a continuation of application No. PCT/US2021/032495, filed on May 14, 2021.
Claims priority of provisional application 63/025,474, filed on May 15, 2020.
Prior Publication US 2023/0295135 A1, Sep. 21, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 405/14 (2006.01)
CPC C07D 405/14 (2013.01) 29 Claims
 
1. A method of treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I-A):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof;
wherein:
Ring A is selected from C3-6cycloalkyl or C6-10aryl;
R1 is selected from H, C1-6alkyl, C1-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, 6- to 10-membered heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more substituents selected from oxo, halo, —OR18, C1-4alkyl, C1-4alkoxy, C1-4heteroalkyl, C1-4haloalkyl, —CN, and NR20R21,
R2 is selected from halo, —CN, —OH, —OMe, —OEt, —NH2, —NHMe, —NMe2, Me, Et, n-Pr, i-Pr, —CF3, and cyclopropyl;
R3 is selected from H, halo, —CN, —OR18, —SOR15, —NR16R17, —C(O)NR16R17, —SO2NR16R17, —C(O)R18, —C(O)OR18, —NR19C(O)R18, —NR19C(O)NR16R17, —NR19SO2R15, —NR19SO2NR16R17, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, and 6- to 10-membered heteroaryl; wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more substituents selected from oxo, halo, —OR18, C1-4alkyl, C1-4alkoxy, C1-4heteroalkyl, C1-4haloalkyl, —CN, and —NR20R21;
R4 is selected from C1-6alkyl, C2-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, 6- to 10-membered heteroaryl, —O(C0-4alkyl)C3-6cycloalkyl, —O(C0-4alkyl)(3- to 10-membered heterocycloalkyl), —O(C0-4alkyl)C6-10aryl, —O(C0-4alkyl)(6- to 10-membered heteroaryl), —O(C0-4alkyl)C(O)OR18, —O(C0-4alkyl)C(O)NR19SO2R15, —O(C0-4alkyl)SO2NR19C(O)R18, —O(C3-6cycloalkyl)C3-6cycloalkyl, —O(C3-6cycloalkyl)(3- to 10-membered heterocycloalkyl), —O(C3-6cycloalkyl)C6-10aryl, —O(C3-6cycloalkyl)(6- to 10-membered heteroaryl), —O(C3-6cycloalkyl)C(O)OR18, —(C1-4alkyl)C3-6cycloalkyl, —(C1-4alkyl)(3 to 10-membered heterocycloalkyl), —(C1-4alkyl)C6-10aryl, —(C1-4alkyl)(6- to 10-membered heteroaryl), and —(C1-4alkyl)C(O)OR18; wherein each alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more substituents selected from C1-4alkyl, oxo, halo, —OR18, —CN, —NR16R17, —C(O)NR16R17, —SO2NR16R17, —C(O)R18, —C(O)OR18, —(C1-4alkyl)OC(O)(C1-4alkyl), —(C1-4alkyl)OC(O)OR18, —NR19C(O)R18, —NR19C(O)NR16R17, —NR19SO2R15, and —NR19SO2NR16R17; and
R4′ and R4″ are each independently selected from H, C1-6alkyl, C2-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, 6- to 10-membered heteroaryl, —O(C0-4alkyl)C3-6cycloalkyl, —O(C0-4alkyl)(3- to 10-membered heterocycloalkyl), —O(C0-4alkyl)C6-10aryl, —O(C0-4alkyl)(6- to 10-membered heteroaryl), —O(C0-4alkyl)C(O)OR18, —O(C0-4alkyl)C(O)NR19SO2R15, —O(C0-4alkyl)SO2NR19C(O)R18, —O(C3-6cycloalkyl)C3-6cycloalkyl, —O(C3-6cycloalkyl)(3- to 10-membered heterocycloalkyl), —O(C3-6cycloalkyl)C6-10aryl, —O(C3-6cycloalkyl)(6- to 10-membered heteroaryl), —O(C3-6cycloalkyl)C(O)OR18, —(C1-4alkyl)C3-6cycloalkyl, —(C1-4alkyl)(3- to 10-membered heterocycloalkyl), —(C1-4alkyl)C6-10aryl, and —(C1-4alkyl)(6- to 10-membered heteroaryl); wherein each alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more substituents selected from oxo, halo, —OR18, —CN, —NR16R17, —C(O)NR16R17, —SO2NR16R17, —C(O)R18, —C(O)OR18, —(C1-4alkyl)OC(O)(C1-4alkyl), —(C1-4alkyl)OC(O)OR18, —NR19C(O)R18, —NR19C(O)NR16R17, —NR19SO2R15, and —NR19SO2NR16R17; or
R3 is H; and R4, R4′, and R4″ are taken together, along with the carbon atom to which they are attached, to form —C(O)R18 or 6- to 10-membered heteroaryl;
R5 is selected from H, C1-6alkyl, C1-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, and 6- to 10-membered heteroaryl; wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more substituents selected from oxo, halo, —OR18, C1-4alkyl, C1-4alkoxy, C1-4heteroalkyl, C1-4haloalkyl, —CN, and NR20R21;
R6 and R7 are each independently selected from H, C1-6alkyl, C1-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, 6- to 10-membered heteroaryl, —(C1-4alkyl)C3-6cycloalkyl, —(C1-4alkyl)(3- to 10-membered heterocycloalkyl), —(C1-4alkyl)C6-10aryl, and —(C1-4alkyl)(6- to 10-membered heteroaryl); wherein each alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently optionally substituted with one or more substituents selected from oxo, halo, —OR18, C1-4alkyl, C1-4alkoxy, C1-4heteroalkyl, C1-4haloalkyl, —CN, and —NR20R21;
R8 and R9 are both H;
each R10 is independently selected from halo, —CN, —OR18, —NR16R17, —C(O)NR16R17, —SO2NR16R17, —C(O)R18, —C(O)OR18, —NR19C(O)R18, C1-6alkyl, C1-6heteroalkyl, C1-6haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl; wherein each alkyl, cycloalkyl, and heterocycloalkyl is independently optionally substituted with one or more substituents selected from oxo, halo, —OR18, C1-4alkyl, C1-4alkoxy, C1-4heteroalkyl, C1-4haloalkyl, —CN, and —NR20R21,
R11, R12, R13, and R14 are each independently selected from H, halo, —CN, —OR18, —NR16R17, —C(O)NR16R17, —SO2NR16R17, —C(O)R18, —C(O)OR18, —NR19C(O)R18, C1-6alkyl, and C1-6haloalkyl;
each R15 is independently selected from C1-4alkyl, C1-4haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, and 6- to 10-membered heteroaryl;
each R16 and R17 is independently selected from H, C1-4alkyl, C1-4heteroalkyl, C1-4haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, 6- to 10-membered heteroaryl; or
an R16 and an R17 may be taken together along with the nitrogen atom to which they are attached to form a 3- to 10-membered heterocycloalkyl;
each R18 is independently selected from H, C1-4alkyl, C1-4heteroalkyl, C1-4haloalkyl, and C3-6cycloalkyl;
each R19 is independently selected from H, C1-4alkyl, C1-4heteroalkyl, C1-4haloalkyl, and C3-6cycloalkyl; and
each R20 and R21 is independently selected from H, C1-4alkyl, C1-4heteroalkyl, C1-4haloalkyl, C3-6cycloalkyl, 3- to 10-membered heterocycloalkyl, C6-10aryl, 6- to 10-membered heteroaryl; or
an R20 and an R21 may be taken together along with the nitrogen atom to which they are attached to form a 3- to 10-membered heterocycloalkyl; and
n is 0, 1, 2, 3, or 4.